ML Score Prediction of Cardiotoxicity in Cancer Patients Receiving Anthracycline Chemotherapy or HER2-Targeted Therapies
NCT07191730
·
clinicaltrials.gov ↗
RECRUITING
Status
600
Enrollment
OTHER
Sponsor class
Conditions
Cardiotoxicity
Heart Failure
Neoplasms
Breast Neoplasms
Sponsor
University Hospital, Caen